Infinity: What the Market's Looking For?

Infinity Pharmaceuticals Inc. turned heads when it raised a $70 million Series B financing round this past June. The start-up founded by very big name scientists and business people says it has spent the past year laying the foundations of a three-part chemistry-screening-assays platform. Managers believe the capacities they're developing and integrating with sophisticated information technology will reinvent drug discovery. The firm is now looking for others that share the vision, and aims to do deals that give the market what it wants.